• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    CDK Global Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    5/18/22 8:11:22 AM ET
    $CDK
    Retail: Computer Software & Peripheral Equipment
    Technology
    Get the next $CDK alert in real time by email
    0001609702 false 0001609702 2022-05-18 2022-05-18 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

     

     

    UNITED STATES 

    SECURITIES AND EXCHANGE COMMISSION 

    Washington, D.C. 20549

     

     

     

    FORM 8-K

     

     

     

    CURRENT REPORT

     

    Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

     

    Date of Report (Date of earliest event Reported): May 18, 2022

     

     

     

    CDK GLOBAL, INC.

    (Exact Name of Registrant as Specified in Charter)

     

     

     

     

    Delaware 001-36486 46-5743146
    (State or Other Jurisdiction of
    Incorporation)
    (Commission File Number) (I.R.S. Employer Identification No.)

     

    1950 Hassell Road 

    Hoffman Estates, IL 60169 

    (Address of Principal Executive Offices) (Zip Code)

     

    (847) 397-1700 

    (Registrant's telephone number, including area code)

     

    Not Applicable 

    (Former name or former address, if changed since last report)

     

     

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
     
    ¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
    ¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
    ¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
    ¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

     

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of each class Trading Symbol(s) Name of each exchange on which
    registered
    Common Stock, $0.01 Par Value CDK NASDAQ Global Select Market

     

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2). Emerging growth company ¨

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

     

     

     

     

     

     

    Item 8.01 Other Events.
       

    On May 18, 2022, CDK Global, Inc. (the “Company”) issued a press release announcing the extension of the expiration date of its previously announced tender offers (the “Tender Offers”) to purchase for cash any and all of its issued and outstanding 4.500% Senior Notes due 2024, the interest rate of which adjusts from time to time and is currently 5.000% (the “2024 Notes”), 4.875% Senior Notes due 2027 (the “2027 Notes”) and 5.250% Senior Notes due 2029 (the “2029 Notes” and, together with the 2024 Notes and the 2027 Notes, the “Notes”) and related solicitation of consents (the “Solicitations”) to the adoption of certain proposed amendments to the indentures governing the Notes. A copy of the press release is attached as Exhibit 99.1 to this Current Report and incorporated by reference herein.

     

    Additional Information

     

    This communication does not constitute an offer to sell or purchase, or a solicitation of an offer to sell or purchase, or the solicitation of tenders or consents with respect to, any security. No offer, solicitation, purchase or sale will be made in any jurisdiction in which such an offer, solicitation or sale would be unlawful. The Tender Offers will only be made pursuant to the terms of the Offer to Purchase and Consent Solicitation Statement and the related Letter of Transmittal and Consent.

     

    The complete terms and conditions of the Tender Offers and Solicitations are set forth in an Offer to Purchase and Consent Solicitation Statement that has been sent to holders of the Notes. Holders are urged to read the tender offer documents carefully before making any decision with respect to the Tender Offers and the Solicitations. Holders of Notes must make their own decisions as to whether to tender any or all of their Notes and provide the related consent.

     

    Item 9.01

     Financial Statements and Exhibits.

       

    (d) Exhibits.

         

    Exhibit Number

      Description
       
    99.1   Press Release of CDK Global, Inc. dated May 18, 2022
    104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

     

     

     

     

    SIGNATURE

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

        CDK GLOBAL, INC.
         
    Date: May 18, 2022 /s/ Lee Brunz
        Lee Brunz
        Executive Vice President, General Counsel and Secretary

     

     

     

    Get the next $CDK alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CDK

    DatePrice TargetRatingAnalyst
    12/16/2021$48.00Overweight → Equal-Weight
    Morgan Stanley
    8/18/2021$62.00 → $56.00Overweight
    Morgan Stanley
    More analyst ratings

    $CDK
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • CDK Global downgraded by Morgan Stanley with a new price target

      Morgan Stanley downgraded CDK Global from Overweight to Equal-Weight and set a new price target of $48.00

      12/16/21 6:51:43 AM ET
      $CDK
      Retail: Computer Software & Peripheral Equipment
      Technology
    • Morgan Stanley reiterated coverage on CDK Global with a new price target

      Morgan Stanley reiterated coverage of CDK Global with a rating of Overweight and set a new price target of $56.00 from $62.00 previously

      8/18/21 7:37:39 AM ET
      $CDK
      Retail: Computer Software & Peripheral Equipment
      Technology
    • Oppenheimer reiterated coverage on CDK Global with a new price target

      Oppenheimer reiterated coverage of CDK Global with a rating of and set a new price target of $65.00 from $55.00 previously

      2/9/21 1:45:55 PM ET
      $CDK
      Retail: Computer Software & Peripheral Equipment
      Technology